The recent success of programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in cancer therapy illustrates the important role of the PD-1/PD-L1 checkpoint in the regulation of antitumor immune responses [6]. Here, PDCD1 is linked to cancer.